These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
1049 related items for PubMed ID: 23314357
1. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53. Lee SY, Shin SJ, Kim HS. Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357 [Abstract] [Full Text] [Related]
2. Nutlin-3 induces BCL2A1 expression by activating ELK1 through the mitochondrial p53-ROS-ERK1/2 pathway. Lee SY, Choi HC, Choe YJ, Shin SJ, Lee SH, Kim HS. Int J Oncol; 2014 Aug; 45(2):675-82. PubMed ID: 24867259 [Abstract] [Full Text] [Related]
3. Nutlin-3 induces HO-1 expression by activating JNK in a transcription-independent manner of p53. Choe YJ, Lee SY, Ko KW, Shin SJ, Kim HS. Int J Oncol; 2014 Mar; 44(3):761-8. PubMed ID: 24366007 [Abstract] [Full Text] [Related]
6. Transactivation of epidermal growth factor receptor mediates catecholamine-induced growth of vascular smooth muscle. Zhang H, Chalothorn D, Jackson LF, Lee DC, Faber JE. Circ Res; 2004 Nov 12; 95(10):989-97. PubMed ID: 15486316 [Abstract] [Full Text] [Related]
7. Insulin-like growth factor-I (IGF-I) induces epidermal growth factor receptor transactivation and cell proliferation through reactive oxygen species. Meng D, Shi X, Jiang BH, Fang J. Free Radic Biol Med; 2007 Jun 01; 42(11):1651-60. PubMed ID: 17462533 [Abstract] [Full Text] [Related]
8. Molecular mechanisms of nutlin-induced apoptosis in multiple myeloma: evidence for p53-transcription-dependent and -independent pathways. Saha MN, Jiang H, Chang H. Cancer Biol Ther; 2010 Sep 15; 10(6):567-78. PubMed ID: 20595817 [Abstract] [Full Text] [Related]
9. Oncogenic tyrosine kinase NPM/ALK induces activation of the MEK/ERK signaling pathway independently of c-Raf. Marzec M, Kasprzycka M, Liu X, Raghunath PN, Wlodarski P, Wasik MA. Oncogene; 2007 Feb 08; 26(6):813-21. PubMed ID: 16909118 [Abstract] [Full Text] [Related]
10. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors. Thottassery JV, Sun Y, Westbrook L, Rentz SS, Manuvakhova M, Qu Z, Samuel S, Upshaw R, Cunningham A, Kern FG. Cancer Res; 2004 Jul 01; 64(13):4637-47. PubMed ID: 15231676 [Abstract] [Full Text] [Related]
11. EGFR-dependent ERK activation triggers hydrogen peroxide-induced apoptosis in OK renal epithelial cells. Lee JS, Kim SY, Kwon CH, Kim YK. Arch Toxicol; 2006 Jun 01; 80(6):337-46. PubMed ID: 16341693 [Abstract] [Full Text] [Related]
12. ERK/MAPK pathways play critical roles in EGFR ligands-induced MMP1 expression. Park S, Jung HH, Park YH, Ahn JS, Im YH. Biochem Biophys Res Commun; 2011 Apr 22; 407(4):680-6. PubMed ID: 21440529 [Abstract] [Full Text] [Related]
13. The transcription-independent mitochondrial p53 program is a major contributor to nutlin-induced apoptosis in tumor cells. Vaseva AV, Marchenko ND, Moll UM. Cell Cycle; 2009 Jun 01; 8(11):1711-9. PubMed ID: 19411846 [Abstract] [Full Text] [Related]
14. Pifithrin-α alters p53 post-translational modifications pattern and differentially inhibits p53 target genes. Zhu J, Singh M, Selivanova G, Peuget S. Sci Rep; 2020 Jan 23; 10(1):1049. PubMed ID: 31974452 [Abstract] [Full Text] [Related]
15. Albumin activates ERK via EGF receptor in human renal epithelial cells. Reich H, Tritchler D, Herzenberg AM, Kassiri Z, Zhou X, Gao W, Scholey JW. J Am Soc Nephrol; 2005 May 23; 16(5):1266-78. PubMed ID: 15829704 [Abstract] [Full Text] [Related]
16. KRAS/BRAF mutation status and ERK1/2 activation as biomarkers for MEK1/2 inhibitor therapy in colorectal cancer. Yeh JJ, Routh ED, Rubinas T, Peacock J, Martin TD, Shen XJ, Sandler RS, Kim HJ, Keku TO, Der CJ. Mol Cancer Ther; 2009 Apr 23; 8(4):834-43. PubMed ID: 19372556 [Abstract] [Full Text] [Related]
17. Extracellular signal-regulated kinase activation by parathyroid hormone in distal tubule cells. Sneddon WB, Yang Y, Ba J, Harinstein LM, Friedman PA. Am J Physiol Renal Physiol; 2007 Mar 23; 292(3):F1028-34. PubMed ID: 17107942 [Abstract] [Full Text] [Related]
18. Neuropeptide Y receptor mediates activation of ERK1/2 via transactivation of the IGF receptor. Lecat S, Belemnaba L, Galzi JL, Bucher B. Cell Signal; 2015 Jul 23; 27(7):1297-304. PubMed ID: 25817573 [Abstract] [Full Text] [Related]
19. [EGFR-ERK signaling pathway down-regulates miRNA-145 in lung cancer cells]. Guo YH, Gao FH, Shi J, Yuan HH, Jiang B. Zhonghua Zhong Liu Za Zhi; 2013 Mar 23; 35(3):187-92. PubMed ID: 23879998 [Abstract] [Full Text] [Related]
20. Agonist-induced activation of histamine H3 receptor signals to extracellular signal-regulated kinases 1 and 2 through PKC-, PLD-, and EGFR-dependent mechanisms. Lai X, Ye L, Liao Y, Jin L, Ma Q, Lu B, Sun Y, Shi Y, Zhou N. J Neurochem; 2016 Apr 23; 137(2):200-15. PubMed ID: 26826667 [Abstract] [Full Text] [Related] Page: [Next] [New Search]